Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia
2020 Standout
Works of Vidje Hansen being referenced
The effect of gender in diagnosing early schizophrenia
2006
Cause-specific mortality in psychiatric patients after deinstitutionalisation
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Vidje Hansen | 177 | 148 | 205 | 204 | 26 | 616 | |
| Bjarne Schmalbach | 110 | 114 | 216 | 130 | 56 | 593 | |
| Chris Thompson | 188 | 130 | 216 | 130 | 35 | 621 | |
| Ying‐Qiang Xiang | 123 | 79 | 213 | 288 | 21 | 735 | |
| M.O. Olatawura | 269 | 109 | 285 | 187 | 23 | 701 | |
| Jessica Dagani | 216 | 112 | 374 | 198 | 21 | 692 | |
| Jess P. Shatkin | 121 | 134 | 209 | 117 | 36 | 583 | |
| Kenneth Lawton | 250 | 146 | 289 | 137 | 11 | 735 | |
| James R. Hillard | 113 | 92 | 375 | 208 | 44 | 708 | |
| Elizabeth A. Klingaman | 97 | 166 | 183 | 146 | 40 | 631 | |
| Agneta Pettersson | 144 | 77 | 297 | 141 | 22 | 733 |
All Works
Loading papers...